SYMORGANIC financials
A multi-period view of the public annual-account figures reported for SYMORGANIC, with comparable measures and links to available source documents.
Company overviewRegistry number
0885054031
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for SYMORGANIC
2025 versus 2024
- Operating line
- €97,428
- EBITDA
- €38,773
- Total assets
- €287,594
- Equity
- €65,614
+7.1%
-3.3%
-7.1%
+7.7%
EBITDA margin +39.8% · Equity ratio +22.8%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.